Health ❯Healthcare ❯Clinical Trials ❯Efficacy Studies

Phase 3 Trials

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

High list prices threaten to limit uptake under looming Medicaid cuts alongside HIV prevention budget reductions

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients